tiprankstipranks
Trending News
More News >
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
US Market

OrthoPediatrics (KIDS) Earnings Dates, Call Summary & Reports

Compare
112 Followers

Earnings Data

Report Date
Apr 30, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-0.43
Last Year’s EPS
-0.3
Same Quarter Last Year
Based on 7 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 04, 2025
|
% Change Since: -4.76%
|
Next Earnings Date:Apr 30, 2025
Earnings Call Sentiment|Positive
OrthoPediatrics reported strong growth and record patient impact for 2024, with significant revenue and adjusted EBITDA improvements. Despite challenges with international sales and gross margin declines due to expense reclassifications, the company remains on track with positive growth projections, successful integration efforts, and new product launches. The restructuring efforts and strategic decisions are aimed at driving long-term profitability.
Company Guidance
During the fourth quarter of 2024, OrthoPediatrics achieved a total revenue of $52.7 million, marking a 40% increase from the previous year, with U.S. revenue seeing a 52% rise to $42.9 million. The company's trauma and deformity business reported revenue of $36.4 million, a 35% increase, while the scoliosis segment grew by 62% to $15.6 million. International sales reached $9.8 million, reflecting a 5% growth, despite deliberate reductions in shipments to South America. The company deployed $3.7 million in sets during the quarter, slightly down from the previous year, and saw its adjusted EBITDA more than double to $3 million. Looking ahead, OrthoPediatrics anticipates full-year 2025 revenue to range from $235 to $242 million, with adjusted EBITDA projected between $15 to $17 million, and expects to achieve its first quarter of positive free cash flow by the fourth quarter of 2025.
Record-High Patient Impact
In 2024, OrthoPediatrics helped over 138,000 kids, a record high for the company, marking significant growth in patient impact.
Revenue and Growth Metrics
Total revenue for Q4 2024 was $52.7 million, representing a 40% growth from the comparable period. The full-year revenue expectation for 2025 is between $235 to $242 million, an annual growth of 15% to 18%.
Significant Growth in Key Segments
TMD and scoliosis segments saw quarterly growth of 35% and 62%, respectively. The scoliosis global revenue increased by 62% compared to the prior year.
Adjusted EBITDA Improvement
Adjusted EBITDA more than doubled in Q4 2024 to $3.0 million, with an expectation of $15 to $17 million in adjusted EBITDA for 2025.
Positive Free Cash Flow Projection
The company expects to achieve its first quarter of positive free cash flow by Q4 2025.
Expansion and Integration Success
Successful integration of Boston OMP and expansion of the OPSB business, with plans for four new territories in 2025.
Strong International Demand
Despite challenges, EMEA T&D growth was strong due to high demand, and non-LATAM T&D growth exceeded 20% with scoliosis growing nearly 30%.
New Product Launches and R&D Advancements
Launches included PMP Tibia and DF2 femur fracture brace, with plans for a beta launch of the 3P hip system and new EOS products.
---

OrthoPediatrics (KIDS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

KIDS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 30, 20252025 (Q1)
-0.44 / -
-0.3
Mar 04, 20252024 (Q4)
-0.30 / -0.29
-0.23-26.09% (-0.06)
Nov 06, 20242024 (Q3)
-0.23 / -0.18
-0.13-38.46% (-0.05)
Aug 05, 20242024 (Q2)
-0.26 / -0.23
-0.19-21.05% (-0.04)
May 06, 20242024 (Q1)
-0.41 / -0.30
-0.29-3.45% (-0.01)
Mar 06, 20242023 (Q4)
-0.27 / -0.23
-0.3228.13% (+0.09)
Nov 06, 20232023 (Q3)
-0.21 / -0.13
-0.05-160.00% (-0.08)
Jul 31, 20232023 (Q2)
-0.20 / -0.19
-0.17-11.76% (-0.02)
May 01, 20232023 (Q1)
-0.35 / -0.29
-0.33.33% (+0.01)
Feb 28, 20232022 (Q4)
-0.23 / -0.32
-0.24-33.33% (-0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

KIDS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 04, 2025$22.89$25.61+11.88%
Nov 06, 2024$30.95$27.49-11.18%
Aug 05, 2024$29.04$27.26-6.13%
May 06, 2024$33.60$34.70+3.27%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does OrthoPediatrics Corp (KIDS) report earnings?
OrthoPediatrics Corp (KIDS) is schdueled to report earning on Apr 30, 2025, TBA Not Confirmed.
    What is OrthoPediatrics Corp (KIDS) earnings time?
    OrthoPediatrics Corp (KIDS) earnings time is at Apr 30, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is KIDS EPS forecast?
          KIDS EPS forecast for the fiscal quarter 2025 (Q1) is -0.43.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis